Concepts (194)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Macrophages | 13 | 2022 | 641 | 1.920 |
Why?
|
| Leukocyte Elastase | 2 | 2025 | 8 | 1.590 |
Why?
|
| Insulin Resistance | 4 | 2022 | 392 | 1.290 |
Why?
|
| Adipose Tissue | 5 | 2022 | 280 | 1.100 |
Why?
|
| Lysosomes | 2 | 2021 | 126 | 0.810 |
Why?
|
| Obesity | 5 | 2022 | 1079 | 0.810 |
Why?
|
| Neutrophils | 2 | 2021 | 346 | 0.750 |
Why?
|
| Neoplasms | 3 | 2025 | 3382 | 0.750 |
Why?
|
| Monocytes | 2 | 2021 | 219 | 0.720 |
Why?
|
| Carcinogenesis | 2 | 2021 | 243 | 0.690 |
Why?
|
| DNA | 3 | 2021 | 1274 | 0.670 |
Why?
|
| Nanoparticles | 1 | 2021 | 219 | 0.580 |
Why?
|
| Triple Negative Breast Neoplasms | 2 | 2019 | 218 | 0.550 |
Why?
|
| Interferon-gamma | 2 | 2018 | 478 | 0.490 |
Why?
|
| Histones | 3 | 2025 | 365 | 0.460 |
Why?
|
| Cell Line, Tumor | 8 | 2025 | 2913 | 0.460 |
Why?
|
| Mice, Inbred C57BL | 10 | 2021 | 3628 | 0.450 |
Why?
|
| Atherosclerosis | 1 | 2018 | 273 | 0.440 |
Why?
|
| Antineoplastic Agents | 1 | 2025 | 2386 | 0.420 |
Why?
|
| CD8-Positive T-Lymphocytes | 3 | 2025 | 701 | 0.410 |
Why?
|
| Mice | 13 | 2025 | 12762 | 0.360 |
Why?
|
| Lactic Acid | 2 | 2025 | 95 | 0.360 |
Why?
|
| Animals | 17 | 2025 | 29045 | 0.340 |
Why?
|
| Energy Metabolism | 3 | 2020 | 314 | 0.300 |
Why?
|
| Cell Proliferation | 3 | 2021 | 1801 | 0.240 |
Why?
|
| Lysine | 2 | 2025 | 170 | 0.230 |
Why?
|
| Phenotype | 5 | 2022 | 2673 | 0.220 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2025 | 559 | 0.200 |
Why?
|
| Glycolysis | 2 | 2025 | 198 | 0.190 |
Why?
|
| Phagosomes | 2 | 2021 | 41 | 0.180 |
Why?
|
| Iron Overload | 1 | 2022 | 8 | 0.180 |
Why?
|
| Humans | 13 | 2025 | 98799 | 0.180 |
Why?
|
| Iron | 2 | 2022 | 178 | 0.170 |
Why?
|
| Culture Media | 1 | 2021 | 138 | 0.170 |
Why?
|
| Ceramides | 1 | 2021 | 36 | 0.170 |
Why?
|
| Eosinophil Cationic Protein | 1 | 2021 | 3 | 0.170 |
Why?
|
| Secretory Leukocyte Peptidase Inhibitor | 1 | 2021 | 4 | 0.170 |
Why?
|
| Cross-Priming | 1 | 2021 | 59 | 0.170 |
Why?
|
| Pancreatic Elastase | 1 | 2021 | 15 | 0.170 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2021 | 67 | 0.170 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2021 | 85 | 0.170 |
Why?
|
| Phagocytosis | 1 | 2021 | 118 | 0.170 |
Why?
|
| Protease Inhibitors | 1 | 2021 | 71 | 0.170 |
Why?
|
| fas Receptor | 1 | 2021 | 73 | 0.160 |
Why?
|
| Allosteric Regulation | 1 | 2021 | 79 | 0.160 |
Why?
|
| Cyclophosphamide | 1 | 2021 | 285 | 0.160 |
Why?
|
| Receptors, Immunologic | 1 | 2021 | 143 | 0.160 |
Why?
|
| Acinetobacter Infections | 1 | 2020 | 19 | 0.160 |
Why?
|
| Nuclear Receptor Co-Repressor 2 | 1 | 2020 | 26 | 0.160 |
Why?
|
| Antigens | 1 | 2021 | 225 | 0.160 |
Why?
|
| Acinetobacter baumannii | 1 | 2020 | 29 | 0.160 |
Why?
|
| Proteolysis | 1 | 2021 | 131 | 0.160 |
Why?
|
| Protein Domains | 1 | 2021 | 169 | 0.160 |
Why?
|
| Immunity | 1 | 2021 | 160 | 0.160 |
Why?
|
| Cell Death | 1 | 2021 | 258 | 0.160 |
Why?
|
| Diet, High-Fat | 2 | 2020 | 144 | 0.150 |
Why?
|
| Protein Isoforms | 1 | 2021 | 305 | 0.150 |
Why?
|
| Cysteine | 1 | 2020 | 151 | 0.150 |
Why?
|
| Mice, Obese | 2 | 2022 | 50 | 0.150 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2020 | 83 | 0.150 |
Why?
|
| Swine | 1 | 2021 | 593 | 0.150 |
Why?
|
| Mice, Knockout | 3 | 2020 | 2217 | 0.150 |
Why?
|
| Cytokine Receptor gp130 | 1 | 2019 | 6 | 0.150 |
Why?
|
| Proteomics | 1 | 2021 | 282 | 0.150 |
Why?
|
| Mammary Glands, Human | 1 | 2019 | 26 | 0.150 |
Why?
|
| Immunotherapy | 1 | 2025 | 831 | 0.150 |
Why?
|
| Membrane Glycoproteins | 1 | 2021 | 446 | 0.140 |
Why?
|
| Hypochlorous Acid | 1 | 2018 | 5 | 0.140 |
Why?
|
| Gallium | 1 | 2018 | 4 | 0.140 |
Why?
|
| Mammary Glands, Animal | 1 | 2019 | 82 | 0.140 |
Why?
|
| Foam Cells | 1 | 2018 | 18 | 0.140 |
Why?
|
| Nitric Oxide | 1 | 2020 | 286 | 0.140 |
Why?
|
| Receptors, Interferon | 1 | 2018 | 32 | 0.140 |
Why?
|
| Receptors, LDL | 1 | 2018 | 54 | 0.140 |
Why?
|
| Hypoxia | 3 | 2025 | 685 | 0.130 |
Why?
|
| Pseudomonas Infections | 1 | 2018 | 95 | 0.130 |
Why?
|
| Combined Modality Therapy | 1 | 2021 | 1754 | 0.130 |
Why?
|
| Interleukin-6 | 1 | 2019 | 283 | 0.130 |
Why?
|
| Respiratory Tract Infections | 1 | 2018 | 112 | 0.130 |
Why?
|
| Myeloid Cells | 1 | 2018 | 126 | 0.130 |
Why?
|
| Autophagy | 2 | 2021 | 176 | 0.130 |
Why?
|
| Weight Loss | 1 | 2019 | 247 | 0.130 |
Why?
|
| Neoplastic Stem Cells | 1 | 2019 | 191 | 0.130 |
Why?
|
| Fluorescent Dyes | 1 | 2018 | 257 | 0.130 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2018 | 208 | 0.120 |
Why?
|
| Cholesterol | 1 | 2018 | 377 | 0.120 |
Why?
|
| Diet | 1 | 2019 | 472 | 0.120 |
Why?
|
| Blood Glucose | 1 | 2020 | 915 | 0.110 |
Why?
|
| Phosphatidylethanolamine Binding Protein | 1 | 2015 | 36 | 0.110 |
Why?
|
| Chemotaxis | 1 | 2015 | 77 | 0.110 |
Why?
|
| Chemokines | 1 | 2015 | 79 | 0.110 |
Why?
|
| Female | 5 | 2025 | 51997 | 0.110 |
Why?
|
| Liver | 1 | 2020 | 1231 | 0.110 |
Why?
|
| Epigenesis, Genetic | 1 | 2019 | 595 | 0.110 |
Why?
|
| Palmitates | 1 | 2014 | 17 | 0.110 |
Why?
|
| Antigens, Surface | 1 | 2014 | 100 | 0.100 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2015 | 130 | 0.100 |
Why?
|
| Culture Media, Conditioned | 1 | 2014 | 102 | 0.100 |
Why?
|
| PPAR gamma | 1 | 2014 | 80 | 0.100 |
Why?
|
| Cell Differentiation | 1 | 2020 | 1656 | 0.100 |
Why?
|
| Melanoma, Experimental | 1 | 2014 | 114 | 0.100 |
Why?
|
| Lipid Metabolism | 1 | 2014 | 221 | 0.100 |
Why?
|
| Inflammation | 2 | 2022 | 1134 | 0.090 |
Why?
|
| Androgens | 1 | 2013 | 164 | 0.090 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2014 | 316 | 0.090 |
Why?
|
| Transcription Factors | 1 | 2020 | 1724 | 0.090 |
Why?
|
| Neoplasm Proteins | 1 | 2015 | 553 | 0.090 |
Why?
|
| Bacterial Infections | 1 | 2013 | 184 | 0.090 |
Why?
|
| Autoimmunity | 1 | 2013 | 195 | 0.090 |
Why?
|
| Cell Membrane | 1 | 2014 | 681 | 0.080 |
Why?
|
| Glucose | 1 | 2014 | 706 | 0.080 |
Why?
|
| Autoimmune Diseases | 1 | 2013 | 262 | 0.080 |
Why?
|
| Neoplasm Metastasis | 1 | 2015 | 1102 | 0.080 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2014 | 229 | 0.080 |
Why?
|
| Tumor Microenvironment | 1 | 2015 | 621 | 0.080 |
Why?
|
| Adipocytes | 2 | 2022 | 181 | 0.080 |
Why?
|
| Gene Expression Regulation | 1 | 2018 | 2023 | 0.070 |
Why?
|
| Cells, Cultured | 1 | 2014 | 2859 | 0.070 |
Why?
|
| Insulin | 1 | 2014 | 1226 | 0.070 |
Why?
|
| Homeostasis | 2 | 2020 | 474 | 0.060 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2013 | 687 | 0.060 |
Why?
|
| Disease Models, Animal | 3 | 2020 | 2581 | 0.060 |
Why?
|
| Lactoylglutathione Lyase | 1 | 2025 | 6 | 0.060 |
Why?
|
| Male | 6 | 2020 | 47475 | 0.050 |
Why?
|
| Cell Hypoxia | 1 | 2025 | 191 | 0.050 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2025 | 177 | 0.050 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2025 | 404 | 0.050 |
Why?
|
| Carbocyanines | 1 | 2021 | 18 | 0.040 |
Why?
|
| RAW 264.7 Cells | 1 | 2021 | 21 | 0.040 |
Why?
|
| Hep G2 Cells | 1 | 2021 | 60 | 0.040 |
Why?
|
| Nanocomposites | 1 | 2021 | 17 | 0.040 |
Why?
|
| Aptamers, Nucleotide | 1 | 2021 | 25 | 0.040 |
Why?
|
| COS Cells | 1 | 2021 | 163 | 0.040 |
Why?
|
| Lung Neoplasms | 1 | 2014 | 2474 | 0.040 |
Why?
|
| Virulence Factors | 1 | 2020 | 117 | 0.040 |
Why?
|
| Multigene Family | 1 | 2020 | 204 | 0.040 |
Why?
|
| Diet, Fat-Restricted | 1 | 2020 | 30 | 0.040 |
Why?
|
| Virulence | 1 | 2020 | 280 | 0.040 |
Why?
|
| Organ Specificity | 1 | 2020 | 287 | 0.040 |
Why?
|
| Protein Multimerization | 1 | 2020 | 195 | 0.040 |
Why?
|
| Acetylation | 1 | 2019 | 151 | 0.040 |
Why?
|
| Inflammation Mediators | 1 | 2020 | 165 | 0.040 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2020 | 213 | 0.040 |
Why?
|
| Bone Marrow Transplantation | 1 | 2020 | 287 | 0.040 |
Why?
|
| Microbial Viability | 1 | 2018 | 34 | 0.040 |
Why?
|
| Sputum | 1 | 2018 | 37 | 0.040 |
Why?
|
| Oxidants | 1 | 2018 | 86 | 0.030 |
Why?
|
| Mutagenesis | 1 | 2018 | 195 | 0.030 |
Why?
|
| Genes, Bacterial | 1 | 2018 | 150 | 0.030 |
Why?
|
| Drug Synergism | 1 | 2018 | 317 | 0.030 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2018 | 89 | 0.030 |
Why?
|
| DNA Transposable Elements | 1 | 2018 | 171 | 0.030 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2018 | 489 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2018 | 417 | 0.030 |
Why?
|
| Cystic Fibrosis | 1 | 2018 | 124 | 0.030 |
Why?
|
| Protein Binding | 1 | 2020 | 1564 | 0.030 |
Why?
|
| Calcium | 1 | 2021 | 1205 | 0.030 |
Why?
|
| Endothelial Cells | 1 | 2020 | 502 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 2019 | 2011 | 0.030 |
Why?
|
| Chromatin | 1 | 2019 | 465 | 0.030 |
Why?
|
| Cyclohexanes | 1 | 2015 | 6 | 0.030 |
Why?
|
| Chemokine CCL5 | 1 | 2015 | 16 | 0.030 |
Why?
|
| Receptors, CCR5 | 1 | 2015 | 22 | 0.030 |
Why?
|
| HMGA2 Protein | 1 | 2015 | 15 | 0.030 |
Why?
|
| RNA, Neoplasm | 1 | 2015 | 87 | 0.030 |
Why?
|
| Heterografts | 1 | 2015 | 121 | 0.030 |
Why?
|
| Transcription, Genetic | 1 | 2019 | 1136 | 0.030 |
Why?
|
| Triazoles | 1 | 2015 | 118 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2015 | 256 | 0.030 |
Why?
|
| Castration | 1 | 2013 | 32 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2015 | 829 | 0.020 |
Why?
|
| Sequence Analysis, RNA | 1 | 2015 | 273 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2019 | 2799 | 0.020 |
Why?
|
| Mice, Inbred NOD | 1 | 2013 | 228 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2015 | 1113 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2015 | 1196 | 0.020 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2014 | 322 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2018 | 885 | 0.020 |
Why?
|
| Metagenome | 1 | 2013 | 123 | 0.020 |
Why?
|
| Bacterial Proteins | 1 | 2018 | 901 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2014 | 722 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2014 | 583 | 0.020 |
Why?
|
| Lung | 1 | 2018 | 1409 | 0.020 |
Why?
|
| Gastrointestinal Tract | 1 | 2013 | 198 | 0.020 |
Why?
|
| Lymphocytes | 1 | 2013 | 461 | 0.020 |
Why?
|
| Sex Characteristics | 1 | 2013 | 353 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 2013 | 825 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2015 | 1572 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2015 | 2076 | 0.020 |
Why?
|
| Mutation | 1 | 2018 | 4443 | 0.020 |
Why?
|
| Young Adult | 1 | 2018 | 7598 | 0.010 |
Why?
|
| Adolescent | 1 | 2018 | 10168 | 0.010 |
Why?
|
| Middle Aged | 1 | 2018 | 29642 | 0.010 |
Why?
|
| Adult | 1 | 2018 | 29698 | 0.010 |
Why?
|